Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Hemochromatosis classification: update and recommendations by the BIOIRON Society

Domenico Girelli, Fabiana Busti, Pierre Brissot, Ioav Cabantchik, Martina U. Muckenthaler, Graça Porto

Blood (2022) 139 (20): 3018–3029.

https://doi.org/10.1182/blood.2021011338

Published: 2022

Includes: Supplemental data

Journal Articles

A Randomised 1 Year Study Evaluating the Impact of Vitamin C Supplementation on Systemic Iron Parameters of Iron Overload in Thalassemia Major Patients on Long-Term Treatment with Deferasirox

Yesim Aydinok, MD, Metin Delebe, MD, Gunes Basol, MD, Selen Bayraktaroglu, MD, Nihal Karadas, MD, Burcu Barutcuoglu, MD, Eser Sozmen, MD, Zvi Ioav Cabantchik, MD PhD

Blood (2016) 128 (22): 1288.

https://doi.org/10.1182/blood.V128.22.1288.1288

Published: 2016

Journal Articles

Iron Chelation For Diseases Of Regional Siderosis

Zvi Ioav Cabantchik, MD PhD, Caroline Moreau, MD PhD, David Devos, MD PhD

Blood (2013) 122 (21): 3435.

https://doi.org/10.1182/blood.V122.21.3435.3435

Published: 2013

Journal Articles

Evaluating Toxic Free Iron and Options for Keeping It At Bay in Iron Overloaded Patients.

Farmaki Kallistheni, MD, Vasilios Berdoukas, MB, BS, Giorgos Chouliaras, MD, Christina Pappa, MD, Zvi Ioav Cabantchik, MD, PhD, Ioanna Tzoumari, MD

Blood (2012) 120 (21): 2110.

https://doi.org/10.1182/blood.V120.21.2110.2110

Published: 2012

Journal Articles

Increased Transferrin Concentration Ameliorates Anemia in Beta-Thalassemic Mice Through Changes in Iron Uptake and TfR1 Trafficking

Huihui Li, MS, Lionel Blanc, PhD, Tenzin Choesang, Maya Shvartsman, Leni vonBonsdorff, PhD, Zvi Ioav Cabantchik, MD, PhD, Yelena Ginzburg, MD

Blood (2011) 118 (21): 906.

https://doi.org/10.1182/blood.V118.21.906.906

Published: 2011

Journal Articles

Comparison of Overt and Cryptic Labile Plasma Iron In Thalassemia Patients In Israel and Gaza-Palestine

William Breuer, Hussam Ghoti, Hesham Jeadi, Ada Goldfarb, Eliezer A. Rachmilewitz, Zvi Ioav Cabantchik

Blood (2010) 116 (21): 5166.

https://doi.org/10.1182/blood.V116.21.5166.5166

Published: 2010

Journal Articles

Apo-Transferrin Injections Reduce Transferrin Receptor 1 Concentration on Erythroid Precursors and Reverse Ineffective Erythropoiesis In Splenectomized Beta-Thalassemic Mice

Huihui Li, MS, Jing Liu, PhD, Jianhua Zhang, MD, Maya Shvartsman, Charles B Hall, PhD, William Breuer, Leni vonBonsdorff, PhD, Zvi Ioav Cabantchik, Xiuli An, MD, PhD, Mohandas Narla, DSc, Yelena Ginzburg, MD

Blood (2010) 116 (21): 4283.

https://doi.org/10.1182/blood.V116.21.4283.4283

Published: 2010

Journal Articles

Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation

Or Kakhlon, Hila Manning, William Breuer, Naomi Melamed-Book, Chunye Lu, Gino Cortopassi, Arnold Munnich, Z. Ioav Cabantchik

Blood (2008) 112 (13): 5219–5227.

https://doi.org/10.1182/blood-2008-06-161919

Published: 2008

Includes: Supplemental data

Journal Articles

Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications

Yang-Sung Sohn, William Breuer, Arnold Munnich, Z. Ioav Cabantchik

Blood (2008) 111 (3): 1690–1699.

https://doi.org/10.1182/blood-2007-07-102335

Published: 2008

Journal Articles

Expression of Genes Regulating Iron Metabolism in Hepatocyte Cell-Line HepG2 Induced by Sera from MDS Patients.

Laura Breda, MD, Hussam Ghoti, MD, Stefano Rivella, MD, Gideon Rechavi, MD, Ioav Cabantchik, MD, Eliezer A. Rachmilewitz, MD

Blood (2007) 110 (11): 4612.

https://doi.org/10.1182/blood.V110.11.4612.4612

Published: 2007

Journal Articles

Selective iron chelation in Friedreich ataxia: biologic and clinical implications

Nathalie Boddaert, Kim Hanh Le Quan Sang, Agnès Rötig, Anne Leroy-Willig, Serge Gallet, Francis Brunelle, Daniel Sidi, Jean-Christophe Thalabard, Arnold Munnich, Z. Ioav Cabantchik

Blood (2007) 110 (1): 401–408.

https://doi.org/10.1182/blood-2006-12-065433

Published: 2007

Journal Articles

Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin

Sara Gardenghi, Maria F. Marongiu, Pedro Ramos, Ella Guy, Laura Breda, Amy Chadburn, YiFang Liu, Ninette Amariglio, Gideon Rechavi, Eliezer A. Rachmilewitz, William Breuer, Z. Ioav Cabantchik, Diedra M. Wrighting, Nancy C. Andrews, Maria de Sousa, Patricia J. Giardina, Robert W. Grady, Stefano Rivella

Blood (2007) 109 (11): 5027–5035.

https://doi.org/10.1182/blood-2006-09-048868

Published: 2007

Includes: Supplemental data

Journal Articles

Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences

Hava Glickstein, Rinat Ben El, Gabi Link, William Breuer, Abraham M. Konijn, Chaim Hershko, Hanspeter Nick, Z. Ioav Cabantchik

Blood (2006) 108 (9): 3195–3203.

https://doi.org/10.1182/blood-2006-05-020867

Published: 2006

Journal Articles

Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells

Hava Glickstein, Rinat Ben El, Maya Shvartsman, Z. Ioav Cabantchik

Blood (2005) 106 (9): 3242–3250.

https://doi.org/10.1182/blood-2005-02-0460

Published: 2005

Journal Articles

Redox active plasma iron in C282Y/C282Y hemochromatosis

Caroline Le Lan, Olivier Loréal, Tally Cohen, Martine Ropert, Hava Glickstein, Fabrice Lainé, Michel Pouchard, Yves Deugnier, André Le Treut, William Breuer, Z. Ioav Cabantchik, Pierre Brissot

Blood (2005) 105 (11): 4527–4531.

https://doi.org/10.1182/blood-2004-09-3468

Published: 2005

Journal Articles

Hepcidin Expression in Cultured Liver Cells Responds Differently to Iron Overloaded Sera Derived from Patients with Thalassemia and Hemochromatosis.

Orly Weizer, Konstantin Adamsky, PhD, Laura Breda, Ioav Cabantchik, MD, PhD, Eliezer Rachmilewitz, MD, William Breuer, PhD, Alon Harmelin, DVM, Carina Levin, MD, Ariel Koren, MD, Ninette Amariglio, PhD, Stefano Rivella, PhD, Gideon Rechavi, MD, PhD

Blood (2004) 104 (11): 3196.

https://doi.org/10.1182/blood.V104.11.3196.3196

Published: 2004

Journal Articles

Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded β-thalassemia/HbE patients treated with an oral chelator

Pensri Pootrakul, William Breuer, Matias Sametband, Pornpan Sirankapracha, Chaim Hershko, Z. Ioav Cabantchik

Blood (2004) 104 (5): 1504–1510.

https://doi.org/10.1182/blood-2004-02-0630

Published: 2004

Journal Articles

Labile plasma iron in iron overload: redox activity and susceptibility to chelation

Breno P. Esposito, William Breuer, Pornpan Sirankapracha, Pensri Pootrakul, Chaim Hershko, Z. Ioav Cabantchik

Blood (2003) 102 (7): 2670–2677.

https://doi.org/10.1182/blood-2003-03-0807

Published: 2003

Journal Articles

Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cells

Gabriela Link, Prem Ponka, Abraham M. Konijn, William Breuer, Z. Ioav Cabantchik, Chaim Hershko

Blood (2003) 101 (10): 4172–4179.

https://doi.org/10.1182/blood-2002-08-2382

Published: 2003

Journal Articles

Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells

Or Kakhlon, Yosef Gruenbaum, Zvi Ioav Cabantchik

Blood (2001) 97 (9): 2863–2871.

https://doi.org/10.1182/blood.V97.9.2863

Published: 2001

NARROW

Hemochromatosis classification: update and recommendations by the BIOIRON Society

A Randomised 1 Year Study Evaluating the Impact of Vitamin C Supplementation on Systemic Iron Parameters of Iron Overload in Thalassemia Major Patients on Long-Term Treatment with Deferasirox

Iron Chelation For Diseases Of Regional Siderosis

Evaluating Toxic Free Iron and Options for Keeping It At Bay in Iron Overloaded Patients.

Increased Transferrin Concentration Ameliorates Anemia in Beta-Thalassemic Mice Through Changes in Iron Uptake and TfR1 Trafficking

Comparison of Overt and Cryptic Labile Plasma Iron In Thalassemia Patients In Israel and Gaza-Palestine

Apo-Transferrin Injections Reduce Transferrin Receptor 1 Concentration on Erythroid Precursors and Reverse Ineffective Erythropoiesis In Splenectomized Beta-Thalassemic Mice

Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation

Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications

Expression of Genes Regulating Iron Metabolism in Hepatocyte Cell-Line HepG2 Induced by Sera from MDS Patients.

Selective iron chelation in Friedreich ataxia: biologic and clinical implications

Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin

Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences

Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells

Redox active plasma iron in C282Y/C282Y hemochromatosis

Hepcidin Expression in Cultured Liver Cells Responds Differently to Iron Overloaded Sera Derived from Patients with Thalassemia and Hemochromatosis.

Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded β-thalassemia/HbE patients treated with an oral chelator

Labile plasma iron in iron overload: redox activity and susceptibility to chelation

Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cells

Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only